US Broker Ratings

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 2.91% Upside with Robust Revenue Growth

For investors seeking exposure in the healthcare technology space, Veeva Systems Inc. (NYSE: VEEV) presents an intriguing opportunity. With a market capitalization of $46.31 billion and..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 37% Upside Potential in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Switzerland-based biotechnology company, is making significant strides in the healthcare sector, particularly in oncology. With a market capitalization of $28.04 billion..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 20% Upside Potential in the Healthcare Sector

IQVIA Holdings, Inc. (NYSE: IQV), a formidable player in the healthcare sector, particularly in diagnostics and research, is presenting an intriguing opportunity for investors. With a..

Hologic, Inc. (HOLX) Stock Analysis: Assessing a Healthcare Pioneer with 3.48% Potential Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector with a solid foothold in medical instruments and supplies, is gaining investor attention as analysts..

BioMarin Pharmaceutical (BMRN) Stock Analysis: Unveiling a 73.65% Potential Upside

For investors seeking promising opportunities within the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents an intriguing case. With a market capitalization of $10.58 billion, BioMarin..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 30.76% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, is capturing attention with its notable potential upside of 30.76%. With a market..

AptarGroup, Inc. (ATR) Stock Analysis: A Closer Look at Its 12.31% Potential Upside

In the competitive sector of healthcare, AptarGroup, Inc. (NYSE: ATR) stands out as a key player in the medical instruments and supplies industry. With a market..

Novo Nordisk A/S (NVO) Stock Analysis: Strong Growth and Impressive 35% Upside Potential

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector with a market capitalization of $304.6 billion, has been catching the eyes of investors, particularly..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating Growth with a 75% Revenue Surge Amidst Market Volatility

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector, attracting significant attention with its impressive revenue growth of 75.40%. This Chicago-based company,..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Uncovering a 27.40% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and a Promising 27.6% Upside Potential

Exact Sciences Corporation (NASDAQ: EXAS), a key player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking exposure to..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 28.68% Potential Upside for Investors

For individual investors seeking opportunities in the healthcare sector, Merck & Company, Inc. (NYSE: MRK) presents a compelling case with a potential upside of 28.68%. With..

Zoetis Inc. (ZTS) Stock Analysis: Strong Buy Ratings and 24.89% Potential Upside Drive Investor Interest

Zoetis Inc. (NYSE: ZTS), a leader in the healthcare sector, continues to capture investor attention with its robust market presence and potential for significant upside. With..

ResMed Inc. (RMD) Stock Analysis: Navigating Growth in Healthcare with a 25.81% ROE

ResMed Inc. (RMD), a titan in the healthcare sector, is making waves in the medical instruments and supplies industry. With a solid market capitalization of $37.41..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 27.49% Potential Upside in the Medical Instruments Sector

Investors are turning their gaze towards Becton, Dickinson and Company (NYSE: BDX), a heavyweight in the healthcare sector specializing in medical instruments and supplies. With a..

Johnson & Johnson (JNJ) Stock Analysis: Exploring a Potential 11% Upside in the Healthcare Giant

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, commands a significant presence in the pharmaceutical and medical technology industries. With a market capitalization..

Smith & Nephew SNATS, Inc. (SNN) Investor Outlook: A 9.7% Upside Potential Amidst Steady Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, stands out in the medical devices industry with its robust market presence and..

Incyte Corporation (INCY): Investor Outlook on Promising Biotech Growth with 9.91% Potential Upside

Incyte Corporation (NASDAQ: INCY) stands as a compelling player in the biotechnology sector, with its focus on the discovery, development, and commercialization of groundbreaking therapeutics. Headquartered..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 17.54% Potential Upside with Analyst Ratings in Focus

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector, operates as a medical device company with a robust portfolio of orthopedic reconstructive..

BioNTech SE (BNTX) Stock Analysis: Navigating a 28% Potential Upside with Strategic Investments in Immunotherapy

BioNTech SE (NASDAQ: BNTX), the German biotechnology powerhouse, has been a focal point for investors aiming to capitalize on advancements in cancer and infectious disease therapies...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds